Intent to Single Source Open Market Items for Admin. Convenience

The Centers for Disease Control and Prevention (CDC) has issued a Special Notice announcing its intent to add open market items to a contemplated blanket purchase agreement (BPA) for immunoglobulin E (IgE) testing services. The notice is being processed in accordance with Federal Acquisition Regulation (FAR) 8.402(f), which allows for administrative convenience in contract modifications. The BPA will utilize a Veterans Administration federal supply schedule contract and involves the addition of specific administrative items to the existing service contract. The Special Notice was posted on February 26, 2025, with a response deadline of February 27, 2025, and is categorized under the Medical Laboratories NAICS code 621511 and Reference Laboratory Testing PSC code Q301.

The primary objective of this Special Notice is to incorporate three specific open market items into the upcoming BPA: an initial requirements checklist for the base period, laboratory manuals, and quarterly reports for both base and optional periods. These additional items represent approximately 2% of the total BPA value and have been preliminarily assessed as fair and reasonable. Interested firms are invited to submit responses demonstrating their capability to meet these requirements by February 27 at 12 p.m. Eastern Time, with submissions to be sent via email to Michael Gilham at ueh8@cdc.gov. While this is not a formal solicitation, the government retains discretion to determine whether to compete these requirements based on the responses received. Contractors should carefully review the attached documentation and be prepared to provide detailed information about their ability to fulfill the specified administrative items for the IgE testing services BPA.